Tinea Pedis Treatment Market Development Leads To High Demand by 2026

Tinea pedis, also known as Athlete's foot, is a fungal infection that occurs between the toes caused by dermatophytes fungi. Often, a sweaty foot enclosed within tight-fitting shoes can cause the fungi to proliferate, leaving an itchy and scaly rash. Being highly contagious, it can spread by sharing rugs, mats, shoes, clothes, or towels with the infected person. The occurrence of tinea pedis is more common in adolescents and males, although cases can also be found in females, children, and the elderly. With the increase in incidence of this fungal infection, the tinea pedis treatment market has witnessed significant growth in recent years. Notably, market growth is particularly robust in tropical environments. Today, manufacturers are driven towards research and development initiatives within the tinea pedis treatment market. In the near future, increase in the incidence of fungal infections and growing elderly population are expected to substantially expand the tinea pedis treatment market.

Looking For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/tinea-pedis-treatment-market/request-sample

Higher Preference for Combination Therapy Creates Robust Demand

In the recent past, combination therapy has emerged as a sound treatment option for tinea pedis. The primary reason for this is the recurring nature of tinea pedis - a factor due to which a second-line of treatment is required. Combination therapy uses systemic and topical treatments to increase the efficacy of the tinea pedis treatment. Since this infection can require strong medication, second-line treatments such as oral antifungals and drying agents are projected to observe an increase in demand in the upcoming years. Over the forecast period, the retail requirement of tinea pedis medicines, widespread prevalence of athlete's foot, and the recurring nature of tinea pedis are expected to increase the demand for tinea pedis treatment.

Interdigital Tinea Pedis is More Widespread, Creating Demand for Topical Antifungals

The types of tinea pedis include interdigital tinea pedis, plantar tinea pedis, and vesicular tinea pedis. Among these, interdigital tinea pedis has emerged as the most common type of tinea pedis infection. This type primarily targets the fourth and fifth toe web spaces, while in some cases, it affects the entire foot. Topical antifungals are the most potent drugs that are widely preferred to treat interdigital tinea pedis. Consequently, in the coming years, low-priced medicines, over-the-counte accessibility of tinea pedis treatment, and higher prevalence of interdigital tinea pedis are poised to take the tinea pedis treatment market to sound maturity.

Do You Have Any Query or Specific Requirement? Request Customization of Report: https://www.fairfieldmarketresearch.com/report/tinea-pedis-treatment-market/request-customization

Europe and North America Dominate Global Tinea Pedis Treatment Market

Europe and the U.S. are the foremost leaders in the global tinea pedis treatment market. In the U.S., major market drivers include well-established healthcare facilities, favorable government policies towards R&D in healthcare, presence of prominent health and pharma industries, and continual rise in the number of patients affected with tinea pedis. As for Europe, during the assessment period, its regional tinea pedis treatment market is expected to flourish due to a steadily growing elderly population.

Major Market Players

The prominent market players operating in the global tinea pedis treatment market are Novan Inc., Johnson & Johnson; Novartis AG, Merck & Co. Inc., Alva-Amco Pharmacal Companies, Inc., Breckenridge Pharmaceutical, Inc., Aurobindo Pharma Limited, Mylan N.V, Cipla Ltd., ProFoot, Inc., Qilu Pharmaceutical Co. Ltd., Taisho Pharmaceutical Co. Ltd., Taro Pharmaceutical Industries Ltd., Sun Pharmaceuticals Limited, Perrigo Company, GlaxoSmithKline plc, and Bayer AG.

For more information: https://www.fairfieldmarketresearch.com/report/tinea-pedis-treatment-market

By Disease Type

• Interdigital Tinea Pedis
• Plantar Tinea Pedis
• Vesicular Tinea Pedis

By Route of Administration

• Oral
• Topical
• Gel
• Creams
• Spray
• Lotions
• Powders
• Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

By Geography

• North America
• Europe
• Asia-Pacific
• LAMEA

Latest Trending Reports:

Zero Liquid Discharge (ZLD) Market: https://world.einnews.com/pr_news/569466361/global-zero-liquid-discharge-zld-market-is-expected-to-be-worth-us-1-639-3-mn-by-2026-from-us-841-4-in-2020-fairfield-market-research

Data Lake Market: https://world.einnews.com/pr_news/569320926/data-lake-market-is-expected-to-be-worth-us-18677-4-mn-by-2026-from-us-8382-3-mn-in-2021-surging-at-a-cagr-of-15-5-fairfield-market-research

Passenger Information System Market: https://world.einnews.com/pr_news/569038709/passenger-information-system-market-it-is-expected-to-reach-us-42-027-mn-by-2026-at-11-9-fairfield-market-research

Contact

Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: sales@fairfieldmarketresearch.com
Web: https://www.fairfieldmarketresearch.com/
Follow Us: https://bit.ly/3voYIm9

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

This release was published on openPR.